ダウンロード数: 1238
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
s00280-013-2151-8.pdf | 450.42 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Kanai, Masashi | en |
dc.contributor.author | Otsuka, Yoshihiko | en |
dc.contributor.author | Otsuka, Kazunori | en |
dc.contributor.author | Sato, Maremi | en |
dc.contributor.author | Nishimura, Takafumi | en |
dc.contributor.author | Mori, Yukiko | en |
dc.contributor.author | Kawaguchi, Michiya | en |
dc.contributor.author | Hatano, Etsuro | en |
dc.contributor.author | Kodama, Yuzo | en |
dc.contributor.author | Matsumoto, Shigemi | en |
dc.contributor.author | Murakami, Yoshiki | en |
dc.contributor.author | Imaizumi, Atsushi | en |
dc.contributor.author | Chiba, Tsutomu | en |
dc.contributor.author | Nishihira, Jun | en |
dc.contributor.author | Shibata, Hiroyuki | en |
dc.contributor.alternative | 金井, 雅史 | ja |
dc.date.accessioned | 2014-09-30T00:16:51Z | - |
dc.date.available | 2014-09-30T00:16:51Z | - |
dc.date.issued | 2013-06 | - |
dc.identifier.issn | 0344-5704 | - |
dc.identifier.uri | http://hdl.handle.net/2433/189888 | - |
dc.description.abstract | A growing number of preclinical studies have demonstrated that curcumin could be a promising anticancer drug; however, poor bioavailability has been the major obstacle for its clinical application. To overcome this problem, we developed a new form of curcumin (Theracurmin) and reported high plasma curcumin levels could be safely achieved after a single administration of Theracurmin in healthy volunteers. In this study, we aimed to evaluate the safety of repetitive administration of Theracurmin in cancer patients. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Springer-Verlag | en |
dc.rights | The final publication is available at Springer via http://dx.doi.org/10.1007/s00280-013-2151-8 | en |
dc.rights | この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。 | ja |
dc.rights | This is not the published version. Please cite only the published version. | en |
dc.subject | Curcumin | en |
dc.subject | Bioavailability | en |
dc.subject | Theracurmin® | en |
dc.subject | Gemcitabine | en |
dc.subject | Pancreatic cancer | en |
dc.subject.mesh | Aged | en |
dc.subject.mesh | Aged, 80 and over | en |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols/administration & dosage | en |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols/adverse effects | en |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols/chemistry | en |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics | en |
dc.subject.mesh | Biliary Tract Neoplasms/drug therapy | en |
dc.subject.mesh | Biliary Tract Neoplasms/metabolism | en |
dc.subject.mesh | Biliary Tract Neoplasms/mortality | en |
dc.subject.mesh | Biological Availability | en |
dc.subject.mesh | Curcumin/administration & dosage | en |
dc.subject.mesh | Curcumin/adverse effects | en |
dc.subject.mesh | Curcumin/chemistry | en |
dc.subject.mesh | Curcumin/pharmacokinetics | en |
dc.subject.mesh | Cytokines/antagonists & inhibitors | en |
dc.subject.mesh | Cytokines/immunology | en |
dc.subject.mesh | Disease-Free Survival | en |
dc.subject.mesh | Dose-Response Relationship, Drug | en |
dc.subject.mesh | Drug Administration Schedule | en |
dc.subject.mesh | Drug Compounding | en |
dc.subject.mesh | Drug Stability | en |
dc.subject.mesh | Female | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Male | en |
dc.subject.mesh | Maximum Tolerated Dose | en |
dc.subject.mesh | Middle Aged | en |
dc.subject.mesh | NF-kappa B/antagonists & inhibitors | en |
dc.subject.mesh | Pancreatic Neoplasms/drug therapy | en |
dc.subject.mesh | Pancreatic Neoplasms/metabolism | en |
dc.subject.mesh | Pancreatic Neoplasms/mortality | en |
dc.subject.mesh | Quality of Life | en |
dc.subject.mesh | Solubility | en |
dc.title | A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.ncid | AA00598397 | - |
dc.identifier.jtitle | Cancer chemotherapy and pharmacology | en |
dc.identifier.volume | 71 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 1521 | - |
dc.identifier.epage | 1530 | - |
dc.relation.doi | 10.1007/s00280-013-2151-8 | - |
dc.textversion | author | - |
dc.identifier.pmid | 23543271 | - |
dcterms.accessRights | open access | - |
出現コレクション: | 学術雑誌掲載論文等 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。